drugset / Trial / NCT02590523
Intracameral Antibiotic Safety Study
RandomizedParallel-groupTriple-blindTreatment
Summary
The goal of this study is to determine the safety (but not efficacy in preventing infection) of sterile-packaged and pre-loaded injectable solutions of both vancomycin and moxifloxacin at certain dosages and concentrations as prepared by a compounding pharmacy when used intracamerally at the time of cataract surgery.
Timeline
- Start
- 2023-01
- Primary completion
- 2024-01
- Completion
- 2024-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | 150 ug | Other |
| Subject | Vancomycin | Other / unclassified | 1 mg | Other |